FBRX
Forte Biosciences Inc
77.00$
+0.0%
vs. previous close
Closing price · As of: Aug 28, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -43.1% | +160.5% | +12.0% | -92.6% | +699.7% | -29.3% | -3.0% | -7.2% | +57.9% | +34.5% | |
| – | -46.1% | +179.2% | +7.9% | -92.3% | +698.0% | -29.0% | -2.4% | -7.7% | +60.1% | +31.4% | |
| – | -32.4% | +552.1% | +13.6% | -83.0% | +746.9% | -28.5% | -2.2% | -70.9% | +86.0% | +246.0% | |
| – | -47.0% | +184.0% | +8.3% | -92.8% | +746.9% | -28.5% | -2.2% | -9.7% | +57.2% | +31.9% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | +67.0% | +63.8% | +226.5% | -96.2% | -36.2% | – | – | – | – | – | |
| – | +22.8% | -26.0% | +114.1% | -95.7% | +18.1% | -22.2% | +80.8% | +15.3% | +147.7% | +139.9% | |
| – | +142.3% | +20.5% | -4.6% | -88.4% | +18.1% | -22.2% | +80.8% | +15.3% | +147.7% | +128.5% | |
| – | +1,100.0% | -34.6% | -99.2% | +13,077.8% | – | – | – | – | – | – | |
| – | +28.2% | +17.1% | +74.5% | -53.9% | -21.0% | -23.7% | +21.9% | +23.5% | +242.6% | +104.7% | |
| – | -19.3% | -73.7% | +622.8% | – | – | – | – | – | – | – | |
| – | -82.1% | +916.0% | -18.2% | -90.1% | +926.5% | -29.6% | -6.6% | -9.0% | +48.6% | +16.2% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | +8.5% | -26.1% | +3,333.3% | -93.7% | +249.1% | +89.8% | +24.5% | +81.6% | +130.9% | +404.7% |
Data as of: August 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.